<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Gao F</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To analyze the clinical efficacy of superficial temporal artery-middle cerebral artery (STA-MCA) bypass grafting surgery combined with temporal muscle patch and STA-MCA bypass grafting surgery alone on patients with moyamoya disease.&lt;h4>Methods&lt;/h4>Totally 73 patients confirmed with moyamoya disease in our hospital between January 2019 and December 2021 were enrolled. Among them, 43 patients treated with STA-MCA bypass grafting surgery combined with temporal muscle patch were assigned to the experiment group, whereas 30 patients treated with STA-MCA bypass grafting surgery alone to the control group. The following items of the 2 groups were compared: clinical efficacy, total effective rate, and disease control rate 6 months after surgery, the changes of modified Rankin Sc</pubmed_abstract><journal>The Journal of craniofacial surgery</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9944694</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical Efficacy of Superficial Temporal Artery-middle Cerebral Artery Bypass Grafting Surgery Combined With Temporal Muscle Patch on Patients With Moyamoya Disease.</pubmed_title><pmcid>PMC9944694</pmcid><pubmed_authors>Gu J</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Gao F</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical Efficacy of Superficial Temporal Artery-middle Cerebral Artery Bypass Grafting Surgery Combined With Temporal Muscle Patch on Patients With Moyamoya Disease.</name><description>&lt;h4>Objective&lt;/h4>To analyze the clinical efficacy of superficial temporal artery-middle cerebral artery (STA-MCA) bypass grafting surgery combined with temporal muscle patch and STA-MCA bypass grafting surgery alone on patients with moyamoya disease.&lt;h4>Methods&lt;/h4>Totally 73 patients confirmed with moyamoya disease in our hospital between January 2019 and December 2021 were enrolled. Among them, 43 patients treated with STA-MCA bypass grafting surgery combined with temporal muscle patch were assigned to the experiment group, whereas 30 patients treated with STA-MCA bypass grafting surgery alone to the control group. The following items of the 2 groups were compared: clinical efficacy, total effective rate, and disease control rate 6 months after surgery, the changes of modified Rankin Sc</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T19:00:29.858Z</modification><creation>2025-04-04T19:00:29.858Z</creation></dates><accession>S-EPMC9944694</accession><cross_references><pubmed>36731073</pubmed><doi>10.1097/SCS.0000000000008992</doi></cross_references></HashMap>